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Abstract. 
 
E1B 19K, the adenovirus Bcl-2 homologue, 
is a potent inhibitor of apoptosis induced by various 
stimuli including Fas and tumor necrosis factor-
 
a
 
. Fas 
and TNFR-1 belong to a family of cytokine-activated 
receptors that share key components in their signaling 
pathways, Fas-associating protein with death domain 
(FADD) and FADD-like interleukin-1
 
b
 
–converting 
enzyme (FLICE), to induce an apoptotic response. We 
demonstrate here that E1B 19K and Bcl-x
 
L
 
 are able to 
inhibit apoptosis induced by FADD, but not FLICE. 
Surprisingly, apoptosis was abrogated by E1B 19K and 
Bcl-x
 
L
 
 when FADD and FLICE were coexpressed. Im-
munofluorescence studies demonstrated that FADD 
expression produced large insoluble death effector fila-
ments that may represent oligomerized FADD. E1B 
19K expression disrupted FADD filament formation 
causing FADD and FLICE to relocalize to membrane 
and cytoskeletal structures where E1B 19K is normally 
localized. E1B 19K, however, does not detectably bind 
to FADD, nor does it inhibit FADD and FLICE from 
being recruited to the death-inducing signaling complex 
(DISC) when Fas is stimulated. Thus, E1B 19K may in-
hibit Fas-mediated cell death downstream of FADD re-
cruitment of FLICE but upstream of FLICE activation 
by disrupting FADD oligomerization and sequestering 
an essential component of the DISC.
 
F
 
as/Apo-
 
1/CD95
 
 
 
(Fas) and tumor necrosis factor re-
ceptor-1 (TNFR-1)
 
1
 
 are related receptor molecules
that play a critical role in inducing cells to commit
apoptosis. Fas plays an integral role in the maintenance of
a homeostatic balance within the immune system through
the removal of activated and self-reactive T and B cells
(for review see Nagata, 1997). Cells undergoing Fas- and
TNF-
 
a
 
–mediated apoptosis display classic apoptotic signa-
tures marked by membrane blebbing, chromatin conden-
sation, nuclear degradation, and the formation of apop-
totic bodies that are engulfed by neighboring cells (Laster
et al., 1988; Itoh et al., 1991).
Fas or Fas ligand deficiency in mice causes lymphopro-
liferative and autoimmune diseases that resemble human
disorders (for review see Nagata, 1997), such as systemic
lupus erythematosus (for review see Thompson, 1995).
TNF-
 
a
 
 has also been implicated in the pathogenesis of
several inflammatory, infectious, and autoimmune dis-
eases. It may play a central role in the development of a
wide range of diseases including diabetes, rheumatoid ar-
thritis, bowel disease, and multiple sclerosis (Klinkert et
al., 1997; Probert et al., 1997).
The cytokines Fas ligand or TNF-
 
a
 
 are the critical com-
ponents necessary for triggering receptor-mediated cell
death in vivo. For example, in the immune privilege sites
of the eye and testes, constitutive expression of Fas ligand
on its cell surface allows these organs to induce apoptosis
in activated T cells that express Fas before an inflamma-
tory response can be mounted (Bellgrau et al., 1995; Grif-
fith et al., 1995). This mechanism for evading an immune
system attack has also been used advantageously by tumor
cells. Fas ligand upregulation in melanoma cells induces
Fas-bearing cytotoxic T lymphocytes and natural killer
cells to undergo apoptosis (Hahne et al., 1996). Thus, can-
cer cells have subverted the Fas pathway to defend them-
selves from immune destruction. As a cellular defense
mechanism, cytotoxic T lymphocytes and natural killer
cells also express Fas ligand, which contributes to immune
surveillance of virally infected cells that are stimulated to
undergo apoptosis and eliminated through the Fas path-
way (for review see Nagata, 1997). Thus, the Fas and TNF-
 
a
 
apoptosis signaling pathways are required for maintaining
homeostasis in the immune system and for defense against
viral infection.
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1. 
 
Abbreviations used in this paper
 
: 
 
b
 
-gal,
 
 b
 
-galactosidase;
 
 
 
BRK, baby rat
kidney; CMV, cytomegalovirus; DD, death domain; DED, death effector
domain; DISC, death-inducing signaling complex; HA, hemagglutinin;
ICE, interleukin-1
 
b
 
–convertase enzyme; TNFR-1, tumor necrosis factor
receptor-1.
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As premature death of an infected host cell can compro-
mise virus replication, viruses have adapted mechanisms
for escaping apoptosis by expression of antiapoptotic
genes. Examples of viral gene products that interfere with
Fas and TNFR-1 death signaling include: BHRF1 from
Epstein-Barr virus (Henderson et al., 1993; Foghsgaard
and Jäättelä, 1997); p35 from 
 
Autographa californica
 
 nu-
clear polyhedrosis virus (Clem et al., 1991; Beidler et al.,
1995); MC159 and MC160 from 
 
Molluscum contagiosum
 
virus (Hu et al., 1997; Thome et al., 1997); E8 from equine
herpesvirus 2 (Hu et al. 1997; Thome et al. 1997); and
CrmA from the cowpox virus (Ray et al., 1992; Enari et al.,
1995; Miura et al., 1995; Tewari and Dixit, 1995). Adenovi-
rus encodes numerous genes whose products block Fas-
and TNF-
 
a
 
–induced apoptosis. These genes include E3
14.7, 10.4, and 14.5 gene products (Gooding et al., 1988,
1991
 
a
 
,
 
b
 
; Shisler et al., 1997), and the E1B 19K gene prod-
uct (Gooding et al., 1991
 
a
 
; Hashimoto et al., 1991; White
et al., 1992).
In addition to effectively inhibiting Fas- and TNF-
 
a
 
–medi-
ated apoptosis, E1B 19K blocks apoptosis induced by ap-
parently unrelated stimuli. During productive adenovirus
infection of human cells, the early gene product E1A stim-
ulates host cell DNA synthesis, thereby causing cells to ab-
errantly go through the cell cycle (Moran, 1993). In re-
sponse to cell cycle deregulation, the host cell undergoes
apoptosis (White et al., 1991). As a defense mechanism,
the E1B 19K protein inhibits this E1A-induced apoptosis
and allows assembly of viral progeny to be completed be-
fore the cell commits suicide (White et al., 1991; Rao et al.,
1992). Bcl-2 is able to functionally complement E1B 19K
during a permissive infection of human cells (Chiou et al.,
1994
 
b
 
). In primary baby rat kidney (BRK) cells, E1A also
deregulates cell cycle control and induces apoptosis; how-
ever, inhibition of apoptosis in this setting by E1B 19K or
Bcl-2 results in transformation (Rao et al. 1992; White et
al., 1992). The induction of apoptosis by E1A in BRK cells
is exclusively dependent on wild-type p53 (Debbas and
White, 1993). E1B 19K, Bcl-2, and Bcl-x
 
L
 
 share the ability
to block this p53-mediated apoptosis (Debbas and White,
1993; Chiou et al., 1994
 
a
 
; Schott et al., 1995). Although Bcl-2,
Bcl-x
 
L
 
, and E1B 19K are all capable of conferring a pro-
tective effect against apoptosis, the effectiveness of each
varies and may be dependent upon the specific cell type
and the death stimuli administered.
In BRK cells, E1A induces accumulation of p53 that
transcriptionally upregulates the death-promoting protein
Bax, leading to activation of downstream caspases and the
final executionary steps in apoptosis (Han et al., 1996
 
a
 
;
Sabbatini et al., 1997). The biochemical mechanism by
which E1B 19K and Bcl-2 disable p53-mediated apoptosis
is partly a consequence of direct binding to Bax and inhibi-
tion of caspase activation (Han et al. 1996
 
a
 
; Sabbatini et al.
1997). Despite these insights into the mechanism by which
E1B 19K inhibits p53-dependent apoptosis, nothing is
known about how it functions to block Fas- and TNF-
 
a
 
–medi-
ated apoptosis.
Over the past several years, the mechanism through
which Fas mediates cell death is beginning to be eluci-
dated. Upon receptor trimerization with Fas ligand or an
anti–APO-1 antibody, Fas is activated and recruits the adap-
tor molecule Fas-associating protein with death domain
(FAAD)/mediator of receptor-induced toxicity (MORT1)
(FADD) to its cytoplasmic region via their corresponding
conserved death domains (DD) (Boldin et al., 1995; Chin-
naiyan et al., 1995; Kischkel et al., 1995). FADD also con-
tains a death effector domain (DED) at its NH
 
2
 
 terminus
responsible for the recruitment of FADD-like ICE (inter-
leukin-1
 
b
 
–convertase enzyme) (FLICE)/MORT1-associ-
ated Ced-3 homologue (MACH)/caspase-8 (FLICE) via its
two DEDs present on its NH
 
2
 
-terminal prodomain (Bol-
din et al., 1996; Muzio et al., 1996). These protein interac-
tions are required for the formation of the death-inducing
signaling complex (DISC) that leads to downstream apop-
totic events (Kischkel et al., 1995). At its COOH terminus,
FLICE is homologous to a cysteine protease that is acti-
vated upon cleavage and is responsible for activation of
downstream caspases leading to the amplification of the
cell death signal and the final executionary steps in apopto-
sis. FADD and FLICE are also activated in the TNFR-1
pathway upon interaction with TNF-
 
a
 
 (for review see Na-
gata, 1997). Receptor stimulation allows FADD, and thereby
FLICE, to interact with the adaptor molecule TRADD
that is recruited to the cytoplasmic region of TNFR-1 caus-
ing FLICE activation and apoptosis (Hsu et al., 1996).
Here we investigate the ability of E1B 19K to block apop-
tosis downstream of Fas. The results implicate FADD
multimerization through its DED as a novel mechanism
for induction of apoptosis. E1B 19K inhibits FADD-induced
cell death coincident with FADD filament disruption and
relocalization to membranes and cytoskeletal structures.
Recruitment of FLICE by FADD allows E1B 19K to block
FLICE-induced apoptosis only in the presence of FADD.
Since E1B 19K does not directly associate with FADD or
FLICE, we conclude another essential DISC component is
mediating this protein interaction. Therefore, we propose
E1B 19K abrogates Fas-mediated apoptosis by disrupting
FADD multimerization and possibly sequestering an inte-
gral protein from the DISC.
 
Materials and Methods
 
Antibodies
 
The following antibodies were used for indirect immunofluorescence, im-
munoprecipitation, and Western blotting analyses: E1B 19K was visual-
ized with the 2F3 monoclonal antibody and a rabbit polyclonal antibody
directed against the E1B 19K protein (Han et al., 1996
 
a
 
; White and Cipri-
ani, 1990). The monoclonal AU1 antibody directed against an AU1
epitope tag was purchased from Berkeley Antibody Co. (Richmond, CA).
The monoclonal HA.11 and the polyclonal HA.11 antibodies directed
against the hemagglutinin (HA) epitope tag were also purchased from
Berkeley Antibody Co. The monoclonal Myc antibody-1 directed against
a Myc epitope tag was purchased from Oncogene Science (Cambridge,
MA). The monoclonal antibody directed against actin was purchased
from Amersham Corp. (Arlington, IL). The anti-Flag M5 monoclonal an-
tibody was purchased from Scientific Imaging Systems (New Haven, CT).
The monoclonal antibody directed against Apo-1/Fas was purchased from
Alexis Biochemicals Corp. (San Diego, CA). A polyclonal antibody di-
rected against FADD was a gift of V. Dixit (University of Michigan, Ann
Arbor, MI).
 
Plasmids
 
pCMV-E1B 19K (White and Cipriani, 1989, 1990)
 
 
 
expresses the wild-type
adenovirus 2 E1B 19K protein from the cytomegalovirus (CMV) pro-
moter and has been previously characterized.
 
 
 
pcDNA3-E1B 19K (Han et al.,
1996
 
a
 
) expresses E1B 19K from a CMV promoter and has been previ- 
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ously described. pCMV-7dl (White et al., 1992) is identical to pCMV-E1B
19K except that it does not express a functional protein due to a frame-
shift mutation at codon 7 within the coding region of the E1B 19K gene.
pCMV-7dl was used as a negative control for E1B 19K function.
pcDNA3-AU1-FADD and pcDNA3-AU1-FADD-DN (Muzio et al.,
1996) are CMV expression vectors for an NH
 
2
 
-terminal AU1-tagged hu-
man FADD and an NH
 
2
 
-terminal AU1-tagged truncated form of FADD
lacking 18 NH
 
2
 
-terminal amino acids, respectively. Both expression vec-
tors were generously provided by V. Dixit. pcDNA3-HA-FLICE (Muzio
et al., 1997) expresses the human FLICE with an influenza virus hemag-
glutinin (HA) epitope tag at its COOH terminus and driven by a CMV
promoter, and was a gift of V. Dixit. pcDNA3-CrmA (Miura et al., 1993)
expresses the cowpox virus ICE inhibitor CrmA from a CMV promoter
and was a gift of J. Yuan (Massachusetts General Hospital, Boston, MA).
pcDNA3-Flag-Bcl-x
 
L, 
 
(Merino et al., 1995) a CMV-driven expression plas-
mid expressing the human Bcl-x
 
L
 
 protein with a Flag-epitope tag at its
NH
 
2 
 
terminus was kindly provided by G. Nunez (University of Michigan,
Ann Arbor, MI). pcDNA3-Myc-hNbk expresses a human Nbk/Bik pro-
tein, with a Myc-epitope tag at its NH
 
2
 
 terminus, from a T7 promoter for in
vitro
 
 
 
transcription/translation as previously described (Han et al., 1996
 
b
 
).
The pcDNA3-Myc-Bcl-2 plasmid expresses human Bcl-2 under the con-
trol of the CMV promoter and was cloned from pGEM2-Bcl-2 (Han et al.
1996
 
a
 
). A specific 5
 
9
 
 primer was used to engineer a KpnI site in front of
the Myc tag and ATG start site. The PCR products were digested with
KpnI and XhoI sites and then ligated into pcDNA3. The pCMV-
 
b
 
-galac-
tosidase (
 
b
 
-gal) expression vector expresses 
 
b
 
-gal from the CMV pro-
moter and was provided by C. Abate-Shen (Center for Advanced Bio-
technology and Medicine and the University of Medicine and Dentistry of
New Jersey, Piscataway, NJ).
 
Indirect Immunofluorescence
 
HeLa cells were transfected with 30 
 
m
 
g of the pCMV-7dl control vector, 8
 
m
 
g of pcDNA3-HA-FLICE, 10 
 
m
 
g of pcDNA3-AU1-FADD, 10 
 
m
 
g of
pcDNA3-FADD-DN, 12 
 
m
 
g of pCMV-E1B 19K, 12 
 
m
 
g of pcDNA3-Myc-
Bcl-2, and 12 
 
m
 
g of pcDNA3-Flag-Bcl-x
 
L 
 
expression plasmids
 
. 
 
Cells were
also transfected with 12 
 
m
 
g of pcDNA3-CrmA expression plasmid to re-
tain cell viability. Cells were fixed at 48 h posttransfection in a 2%
paraformaldehyde solution and then permeabilized with PBS containing
0.5% Triton X-100 (Sigma Chemical Co., St. Louis, MO). Cells were dou-
ble labeled with the indicated antibodies and visualized with goat anti–
mouse rhodamine-conjugated and goat anti–rabbit fluorescein-conjugated
secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA). Photography was performed using a microscope equipped
with epifluorescence optics (model FXA; Nikon Inc., Garden City, NY).
 
Western Blotting
 
Whole cell extracts were prepared for Western blot analysis 48 h post-
transfection. 20 
 
m
 
g of protein from each sample were analyzed by SDS-
PAGE and semidry-blotted onto nitrocellulose membranes. Proteins were
detected by enhanced chemiluminescence and used according to the man-
ufacturer’s specifications (Amersham Corp.).
 
In Vitro Protein Interaction Assay
 
Expression vectors encoding E1B 19K (pcDNA3-E1B 19K), FADD
(pcDNA3-AU1-FADD), FADD-DN (pcDNA3-AU1-FADD-DN), FLICE
(pcDNA3-HA-FLICE), and Nbk/Bik (pcDNA3-Myc-hNbk), were in
vitro transcribed and translated according to the manufacturer’s specifica-
tions (Promega Corp., Madison, WI). The in vitro translated 
 
35
 
S-labeled
proteins were titrated to equal concentrations and incubated with an anti-
FADD polyclonal antibody or an anti-E1B 19K polyclonal antibody (see
figure legend) in the presence of 0.5 ml NETN lysis buffer (20 mM Tris,
pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.2% NP-40) (Han et al., 1996
 
a
 
).
Protein complexes were collected with protein A–Sepharose (Pharmacia
Biotech Inc., Piscataway, NJ) and washed three times with NETN buffer.
Proteins were resolved on a 17% SDS-PAGE gel and then subjected to
autoradiography.
 
Immunoprecipitation
 
HeLa cells were transiently transfected with 3 
 
m
 
g of pcDNA3-HA-FLICE,
3 of 
 
m
 
g pcDNA3-AU1-FADD, 12 
 
m
 
g of pCMV-E1B 19K, and 12 
 
m
 
g of
pcDNA3-CrmA expression plasmids as indicated in Fig. 8, and then sub-
jected to immunoprecipitation analysis at 48 h posttransfection (Kischkel
et al. 1995). Briefly, a 10-cm plate
 
 
 
of cells was trypsinized, centrifuged at
1,000 
 
g
 
, and then resuspended in 37
 
8
 
C DME. Fas receptor was stimulated
by preincubation with 2 
 
m
 
g/ml of anti–APO-1 antibody for 15 min and
then immediately placed on ice. Cells were washed in PBS and lysed in 1 ml
of lysis buffer (as stated above) containing 1% Triton X-100 and 10%
glycerol for 30 min at 4
 
8
 
C. Lysates were centrifuged and protein A–Seph-
arose (Pharmacia Biotech Inc.) was added to the supernatant. As a nega-
tive control, 2 
 
m
 
g/ml of anti–APO-1 antibody and protein A–Sepharose
were added to the lysates of unstimulated cells. Lysates were incubated at
4
 
8
 
C on a rotator (Labquake Shaker model 400110; Barnstead/Thermolyne
Inc., Dubuque, IA) for 3 h. The beads were washed five times in lysis
buffer, boiled for five minutes in Laemmli buffer (Laemmli, 1970), and then
resolved by SDS-PAGE analysis. Immunoprecipitated FADD and FLICE
were detected using Western blot analysis by probing with anti-FADD
polyclonal and anti-HA polyclonal antibodies, respectively.
 
Viability Assays
 
Induction of cell death by FADD and its inhibition by Bcl-2 family mem-
bers was assessed by a 
 
b
 
-gal viability assay (Han et al., 1996
 
b
 
). HeLa cells
(6-cm plates) were electroporated, as previously described (Chiou et al.,
1994
 
a
 
), with 18 
 
m
 
g of the pCMV-7dl control vector, 6 
 
m
 
g of pcDNA3-
AU1-FADD, 12 
 
m
 
g of pCMV-E1B 19K, 12 
 
m
 
g of pcDNA3-Myc-Bcl-2, and
12 
 
m
 
g of pcDNA3-Flag-Bcl-x
 
L
 
 expression plasmids, as indicated in the
text. All samples were also transfected with 6 
 
m
 
g of pCMV-
 
b
 
-gal DNA.
Total DNA transfected was kept constant at 18 
 
m
 
g. 48 h posttransfection,
cells were fixed and the percentage of viable blue cells assessed by
5-bromo-4-chloro-3-indoxyl-
 
b
 
-
 
d
 
-galactopyranoside staining and examined
by phase-contrast microscopy as previously described (Han et al., 1996
 
b
 
).
FLICE functional assays were performed by transfecting HeLa cells
with 30 
 
m
 
g of the pCMV-7dl control vector, 8 
 
m
 
g of pcDNA3-HA-FLICE,
10 of 
 
m
 
g pcDNA3-AU1-FADD, 12 
 
m
 
g of pCMV-E1B 19K, 12 
 
m
 
g of
pcDNA3-Myc-Bcl-2, and 12 
 
m
 
g of pcDNA3-Flag-Bcl-x
 
L
 
 expression con-
structs as indicated in Fig. 1 
 
b
 
. 10 
 
m
 
g of pCMV-
 
b
 
-gal was added to all the
samples and the total DNA concentration was kept constant at 30 
 
m
 
g. Vi-
ability was assessed as stated above.
 
Results
 
E1B 19K and Bcl-x
 
L
 
 Inhibit FADD but Not
FLICE-induced Apoptosis
 
The adenoviral E1B 19K protein is a potent inhibitor of
Fas- and TNF-
 
a
 
–induced apoptosis (Gooding et al. 1991
 
a
 
;
Hashimoto et al. 1991; White et al. 1992). Other Bcl-2 fam-
ily members, however, vary in their ability to block death
receptor–mediated apoptosis (Chiou et al. 1994
 
b
 
; Arm-
strong et al., 1996; Chinnaiyan et al., 1996
 
a
 
;  Nagata 1997).
We sought to identify at which point in the signaling cas-
cade E1B 19K, Bcl-2, and Bcl-x
 
L
 
 interfere with apoptosis
induction by Fas and TNF-
 
a
 
, and whether they act by a
similar mode to inhibit cell death.
E1B 19K, and to a lesser extent Bcl-2, have been shown
to abrogate Fas- and TNF-
 
a
 
–induced apoptosis in HeLa
cells (Gooding et al., 1991
 
a
 
; White et al., 1992; Chiou et al.,
1994
 
b
 
; Armstrong et al., 1996). Since E1B 19K does not af-
fect the presence of the TNF receptors at the cell surface
of adenovirus infected cells, we have postulated E1B 19K
must be acting at, or downstream of, the receptor to block
cell death (White et al., 1992). To determine at which
point downstream of death receptors the survival signal is
exerted, we examined the ability of E1B 19K, Bcl-2, and
Bcl-x
 
L
 
 to inhibit FADD- and FLICE-induced death.
Transient expression of FADD in HeLa cells caused
only 10% of the transfected cells to remain viable com-
pared with transfection with a plasmid control pm7dl
(7dl), that does not express a functional protein (Fig. 1 
 
a
 
). 
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CrmA acts as a competitive inhibitor for the ICE-related
proteases, and has been shown to abrogate both Fas- and
TNF-
 
a
 
–mediated apoptosis (Enari et al., 1995; Miura et al.,
1995; Tewari and Dixit, 1995). As a positive control for apop-
tosis inhibition, FADD was coexpressed with the ICE in-
hibitor CrmA, which restored cell viability, as expected
(Fig. 1 a). FADD was then coexpressed with E1B 19K, to
determine if apoptosis could be abrogated (Fig. 1 a). Ap-
proximately 90% of the cells survived when E1B 19K pro-
tein was coexpressed with FADD. Thus, E1B 19K po-
tently inhibits both Fas- and FADD-induced apoptosis.
Bcl-2 and Bcl-xL were similarly examined for suppres-
sion of FADD-induced death. Hela cells were cotrans-
fected with FADD, and either Bcl-2 or Bcl-xL. Although
both Bcl-2 and Bcl-xL were highly expressed, Bcl-2 was not
able to block FADD-induced death. In fact, overexpres-
sion of Bcl-2 in HeLa cells appears to be partially toxic as
indicated by the 50% reduction in viability (Fig. 1 a). In
contrast, Bcl-xL restored viability to FADD-transfected
cells to a similar extent as E1B 19K expression (Fig. 1 a).
These results correlate with the ability of E1B 19K, and
not Bcl-2, to nearly completely abrogate Fas-induced cell
death (Gooding et al., 1991a; White et al., 1992; Chiou et al.,
1994b). Therefore, we conclude Bcl-xL and E1B 19K, but
not Bcl-2, can ablate the apoptotic function of FADD
downstream of Fas.
FLICE activation is induced upon its recruitment to the
DISC that is mediated through DEDs in the prodomain of
FLICE interacting with FADD (Boldin et al., 1996; Muzio
et al., 1996). We addressed whether inhibition of cell death
was acting at FADD or further downstream at FLICE.
FLICE was expressed alone or in the presence of E1B
19K, Bcl-2, and Bcl-xL (Fig. 1 b). FLICE overexpression
caused a 50% reduction in cell viability compared with the
plasmid control 7dl. Coexpression of E1B 19K, Bcl-2, or
Bcl-xL did not significantly increase cell survival upon
FLICE overexpression. In conclusion, E1B 19K and Bcl-
xL, but not Bcl-2, can inhibit FADD-induced cell death,
but neither E1B 19K or Bcl-xL can block cell death upon
FLICE overexpression.
E1B 19K and Bcl-xL Inhibit FLICE-induced Apoptosis 
in the Presence of FADD
As implicated in the FADD and FLICE functional assays,
inhibition of apoptosis was upstream of FLICE and thus
possibly acting at FADD. To further address where the
Bcl-2 family of inhibitors exert their protective effects,
FADD and FLICE were coexpressed alone or in the pres-
ence of E1B 19K, Bcl-xL, or Bcl-2. When FADD was coex-
pressed with FLICE, apoptosis was increased significantly
compared with FLICE overexpression (Fig. 1 b). E1B 19K
expression nearly completely abrogated cell death when
FADD and FLICE were coexpressed (Fig. 1 b). This inhi-
bition in cell death by E1B 19K was just as efficient as that
of the CrmA control. Thus, E1B 19K, despite being unable
to block cell death upon FLICE activation, was able to
block FLICE-induced apoptosis in the presence of overex-
pressed FADD.
Similarly, Bcl-xL and Bcl-2 were coexpressed with
FADD and FLICE to determine if they possessed a simi-
lar activity to that of the E1B 19K protein. A dramatic in-
Figure 1.( a ) E1B 19K and Bcl-xL abrogate FADD-mediated apop-
tosis. HeLa cells were transfected with FADD alone or cotrans-
fected with Bcl-2, Bcl-xL, or E1B 19K. Bcl-2, Bcl-xL, and E1B
19K were also each expressed individually as controls. A b-gal
viability assay was performed 48 h posttransfection. The percent-
age of viable cells was compared with 7dl transfected vector con-
trol cells. The values represent data from a single experiment that
was reproducible in three independent experiments. (b) E1B 19K
and Bcl-xL block FLICE-mediated cell death only in the presence
of the FADD adaptor molecule. HeLa cells were transfected with
FLICE alone or coexpressed with Bcl-2, Bcl-xL, E1B 19K, or
FADD. Cells were transfected with FADD and FLICE in the
presence of Bcl-2, Bcl-xL, or E1B 19K. Bcl-2, Bcl-xL, and E1B 19K
were also each expressed alone as a control. Viability was assessed
48 h posttransfection and compared with the 7dl vector control.Perez and White E1B 19K Inhibits Adaptor-dependent Caspase Activation 1259
crease in viable cell number was observed when Bcl-xL,
and less profoundly when Bcl-2, were coexpressed with
FADD and FLICE (Fig. 1 b). Taken together, these re-
sults suggest that Bcl-2 is not very proficient at blocking
Fas-mediated apoptosis, or may be acting differently from
E1B 19K and Bcl-xL.
E1B 19K Disrupts FADD Filament Formation
E1B 19K is found to associate with the nuclear lamina as
well as the cytoplasmic and nuclear membranes (White et
al., 1984; White and Cipriani, 1990). Previous experiments
have shown E1B 19K partially colocalizes with Bax in cy-
toplasmic membranes and inhibits cell death through di-
rect interaction with Bax during p53-mediated apoptosis
(Han et al., 1996). To gain insight into the mechanism
through which E1B 19K abrogated FADD-induced, as
well as FLICE-induced apoptosis in the presence of
FADD, indirect immunofluorescence was performed.
HeLa cells were transfected with either an AU1-tagged
FADD, or an HA-tagged FLICE, alone or in the presence
of E1B 19K. Double-label indirect immunofluorescence at
48 h posttransfection was performed to ascertain whether
the subcellular localization of FADD or FLICE could be
altered in the presence of E1B 19K.
HeLa cells were transfected with HA-tagged FLICE
and protein expression was visualized with an anti-HA
polyclonal antibody. Cells transiently transfected with
FLICE demonstrated a diffuse cytoplasmic and nuclear
staining that was not observed in vector control trans-
fected cells (Fig. 2, A and B). Although diffuse staining
patterns as we have observed for FLICE are less obvious
by indirect immunofluorescence than proteins displaying a
discrete localization pattern, FLICE-positive cells were
clearly visible. E1B 19K localized to the cytoplasmic and
nuclear membranes and the cytoskeletal structures as pre-
viously reported (Fig. 2 D) (White and Cipriani, 1989,
1990) Co-expression of E1B 19K with FLICE did not alter
the subcellular localization of FLICE, nor was any colocal-
ization of the two proteins observed (Fig. 2, C and D).
HeLa cells transiently expressing AU1-tagged FADD
were stained with an anti-FADD polyclonal or anti-AU1
monoclonal antibodies. The staining pattern of FADD
was strikingly different from FLICE, with FADD overex-
pression causing the formation of large filamentous struc-
tures in the nucleus and cytoplasm that react with anti-
FADD or anti-FADD epitope tag antibodies (Fig. 3 B).
These structures were not present in the 7dl vector con-
trol–transfected cells (Fig. 3 A). Yeast two-hybrid experi-
ments have shown FADD self-associates and this oligo-
merization process may be essential for the induction of
cell death (Boldin et al., 1995). This is similar to the man-
ner in which Fas receptor trimerization is required for
transduction of the death signal (Kischkel et al., 1995).
Thus, filament formation due to FADD overexpression
may result from FADD multimerization.
To address whether E1B 19K can alter the subcellular
localization of FADD, immunofluorescence studies with
E1B 19K coexpression were performed. As shown in Fig.
3 C, coexpression of FADD with E1B 19K dramatically al-
tered the localization pattern of FADD, with complete
disruption of the filaments into large aggregates in the cy-
toplasm. However, FADD filaments within the nucleus
did not appear affected as indicated by phase-contrast and
electron microscopy (data not shown). E1B 19K does not
localize within the nucleus and, therefore, may not be able
to disrupt nuclear FADD filaments. Double labeling with
an anti-E1B 19K monoclonal antibody and an anti-FADD
polyclonal antibody revealed complete colocalization of
the two proteins, with FADD displaying the typical local-
ization of the E1B 19K protein (cytoplasmic and nuclear
membranes as well as the cytoskeletal structures) (Fig. 3,
C and D).
An AU1-tagged FADD-DN, a death effector domain
deletion mutant that does not self-associate or induce
death, was visualized with an anti-AU1 monoclonal anti-
body (Boldin et al., 1995; Chinnaiyan et al., 1996b). Its ex-
pression pattern was diffuse within the cytoplasm and nu-
cleus similar to that of FLICE (Fig. 3 F). This result
suggests that FADD filament formation, and thus oligo-
merization, may play an integral role in mediating apopto-
sis. As seen in Fig. 3, G and H, addition of E1B 19K did
not change FADD-DN subcellular localization, suggesting
that colocalization of E1B 19K with FADD requires either
full-length or the DED of FADD.
FADD Recruits FLICE into Filaments That Are 
Disrupted by E1B 19K
To ascertain whether FADD could alter the localization of
FLICE, Hela cells transiently coexpressing AU1-tagged
FADD and HA-tagged FLICE were examined by indirect
Figure 2. FLICE has a diffuse cytosolic and nuclear staining pat-
tern and E1B 19K does not alter its subcellular localization.
HeLa cells were transfected with the expression plasmids indi-
cated and processed for indirect immunofluorescence 48 h post-
transfection. HeLa cells were transfected with the 7dl vector con-
trol and stained with an anti-HA polyclonal antibody (A). HeLa
cells were transfected with HA-tagged FLICE and stained with
an anti-HA polyclonal antibody (B). In C and D, cells were trans-
fected with HA-tagged FLICE plus E1B 19K and stained with an
anti-HA polyclonal antibody (C) and an antibody directed
against E1B 19K (D). Cells were also transfected with CrmA to
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immunofluorescence with anti-FADD and anti-HA anti-
bodies, respectively. The intracellular staining pattern of
FADD remained as large filaments, however, FLICE no
longer had a diffuse cytosolic pattern (Fig. 4 A) but was re-
cruited by FADD into the large filamentous structures as
evidenced by the colocalization of FADD and FLICE
(Fig. 4 B). Thus, FADD was able to alter the localization
pattern of FLICE most likely through a direct protein–
protein interaction with FLICE. We were, however, not
able to detect endogenous FADD or FLICE filaments be-
cause antibodies sufficient to detect the endogenous pro-
teins by indirect immunofluorescence were not available.
To test if E1B 19K could alter the localization of both
FADD and FLICE, E1B 19K was coexpressed with both,
and the transfected cells were examined by indirect immu-
nofluorescence for E1B 19K, FADD, and FLICE. Fig. 4,
C–E demonstrates that coexpression of FLICE and
FADD in the presence of E1B 19K significantly altered
the diffuse cytosolic distribution of FLICE such that
FLICE colocalized with both FADD and E1B 19K (Fig. 4
D). FADD directly binds to FLICE and by E1B 19K alter-
ing the localization of FADD, E1B 19K apparently alters
the localization of FLICE (Fig. 4, C–E). The alteration in
localization of FADD and FLICE by E1B 19K suggests
that the ability of E1B 19K to protect the cells from apop-
tosis may be through functional sequestration of both
FADD and FLICE.
Bcl-xL Expression Attenuates FADD
Filament Formation
To address whether other Bcl-2 homologues may also im-
plement a similar mechanism for inhibition of FADD-
induced apoptosis, immunofluorescence studies were exe-
cuted with Bcl-2 and Bcl-xL. Bcl-2 and Bcl-xL localize at
the mitochondrial, endoplasmic reticulum, and nuclear
membranes (Figs. 5 B and 6 B) (for review see White,
1996). In HeLa cells, transient FLICE expression re-
mained diffuse throughout the cytoplasm and nucleus
even when FLICE was coexpressed with Bcl-2 or Bcl-xL,
(Figs. 5 A and 6 A, respectively).
When FADD was coexpressed with Bcl-2, FADD fila-
ments were still apparent but reduced in length or in num-
ber (Fig. 5 D) compared with that of FADD overexpres-
sion alone (Fig. 5 C). In contrast, overexpression of Bcl-xL
substantially attenuated the degree of FADD filament for-
mation. Bcl-xL expression caused FADD filaments to be
highly disrupted (Fig. 6 D). Occasionally, FADD-express-
ing cells displayed filament formation in the presence of
Bcl-xL. These cells, however, routinely expressed unusu-
ally high levels of Bcl-xL, suggesting a concentration de-
pendence of the ability of Bcl-xL to disrupt FADD fila-
ments. However, in contrast to E1B 19K, Bcl-xL does not
colocalize with FADD. These results suggest that Bcl-2
and Bcl-xL have a differential effect on FADD filament
formation and that Bcl-xL inhibits Fas-mediated apoptosis
differently than E1B 19K.
When HeLa cells were transiently transfected with
FADD, FLICE, and either Bcl-2 or Bcl-xL, FLICE re-
mained diffuse throughout the cell (Figs. 5 G and 6 G, re-
spectively). When FADD, FLICE, and Bcl-2 were coex-
pressed, the appearance of FADD filaments remained
consistent with that of FADD and Bcl-2 coexpression
alone. Together, these results suggest that FADD failed to
recruit FLICE into these filaments in the presence of Bcl-2
(Fig. 5, G and F). Coexpression of Bcl-xL with FADD and
Figure 3. Overexpression of FADD and not a FADD-DN mutant forms filamentous structures that are disrupted by E1B 19K expres-
sion. HeLa cells were transfected with the 7dl vector control and stained with an anti-FADD antibody (A). In B, cells were transfected
with AU1-tagged FADD and protein expression detected with an anti-FADD polyclonal antibody. In C and D, HeLa cells coexpressed
AU1-tagged FADD and E1B 19K and were stained with an anti-FADD polyclonal antibody (C) and an anti-E1B 19K monoclonal anti-
body (D). HeLa cells were transfected with 7dl vector control and stained with an anti-AU1 monoclonal antibody (E). Cells were trans-
fected with AU1-tagged FADD-DN alone (F) or in the presence of E1B 19K (G and H). FADD-DN protein expression was visualized
with an anti-AU1 monoclonal antibody (F and G) and E1B 19K detected with a polyclonal antibody directed against it (H). All cells
were also transfected with CrmA to retain cell viability.Perez and White E1B 19K Inhibits Adaptor-dependent Caspase Activation 1261
FLICE profoundly disrupted FADD filaments in almost
all transfected cells (Fig. 6 F). In contrast to the results in
E1B 19K–expressing cells, there was no colocalization of
FLICE and FADD when Bcl-2 or Bcl-xL was coexpressed
(Figs. 5 and 6). Therefore, we conclude, Bcl-xL alters the
ability of FADD to polymerize and recruit FLICE,
whereas E1B 19K apparently disrupts FADD organiza-
tion without affecting FLICE recruitment.
E1B 19K Does Not Interact with FADD or FLICE
In Vitro
The E1B 19K protein is predominantly insoluble and
bound to the membranes and cytoskeleton in adenovirus
infected and transformed cells (White et al., 1984; White
and Cipriani, 1989, 1990). Alteration in FADD and
FLICE subcellular localization by E1B 19K and colocal-
ization with E1B 19K suggested that E1B 19K, FADD,
and FLICE may directly associate to form an insoluble
protein complex. To examine the ability of E1B 19K to as-
sociate with FADD or FLICE in vitro, E1B 19K, FADD,
and FLICE were in vitro transcribed/translated and ana-
lyzed by coimmunoprecipitation. As expected, an anti-
FADD antibody was able to coimmunoprecipitate FADD
and FLICE but there was no detectable interaction be-
tween FADD-DN and FLICE (Fig. 7, lanes 1 and 2). In-
terestingly, coincubation of FADD and FLICE caused the
appearance of a 21-kD band that was not detectable in in-
dividually in vitro–translated FADD or FLICE. Whether
this band represents a FADD or FLICE cleavage product
remains to be determined. An E1B 19K-specific antibody
was not able to coimmunoprecipitate E1B 19K with either
FADD or FLICE individually or when cotranslated (Fig.
8, lanes 3–5). The E1B 19K interacting protein Nbk/Bik
served as a positive control for the presence of a direct
protein–protein interaction with E1B 19K (Fig. 7, lane 6).
Figure 4. E1B 19K disrupts FADD filament formation and colocalizes with
FLICE in the presence of the FADD adaptor molecule. HeLa cells were trans-
fected with HA-tagged FLICE or coexpressed with HA-tagged FLICE plus AU1-
tagged FADD (A and B, respectively). FLICE was visualized with an anti-HA an-
tibody (A and B). In C–E HeLa cells transiently coexpressed AU1-tagged
FADD, HA-tagged FLICE, and E1B 19K. A polyclonal antibody directed against
FADD (C), an anti-HA polyclonal antibody directed against the epitope tag on
FLICE (D), and monoclonal antibody directed against E1B 19K (E) was used to
visualize protein expression. All cells were also transfected with CrmA to retain
cell viability.The Journal of Cell Biology, Volume 141, 1998 1262
Yeast two-hybrid analysis has also confirmed no detect-
able direct association between FADD or the prodomain
of FLICE with E1B 19K (data not shown). Thus, we can
conclude E1B 19K does not directly interact with FADD
or FLICE, or that FADD and/or FLICE require modifica-
tion that does not take place in vitro or in yeast to interact
with E1B 19K.
E1B 19K Does Not Inhibit FADD and FLICE from 
Being Recruited to the DISC
Coimmunoprecipitation experiments revealed that en-
gagement of Fas receptor with anti–APO-1 antibody re-
cruits FADD and FLICE to the cytoplasmic domain of
Fas, and this protein complex collectively forms the DISC
(Kischkel et al., 1995). This multiprotein interaction may
allow FLICE to undergo autocatalytic activation and to in-
duce apoptosis. To address whether E1B 19K was able to
abrogate DISC formation, HeLa cells overexpressing
FADD, FLICE, and CrmA, with and without E1B 19K,
were subjected to Fas activation using an anti–APO-1
monoclonal antibody (Fig. 8 a). HeLa cells were first pre-
incubated with an anti–APO-1 antibody for 15 min before
cell lysis (Fig. 8 a, lanes 1, 3, and 5). Immune complexes
were collected with protein A and subjected to immuno-
blot analysis using an anti-FADD polyclonal antibody. As
a negative control for Fas-interacting proteins, the cell ly-
sates were generated without receptor engagement with
the addition of an anti–APO-1 antibody after cell lysis
(Fig. 8 a, lanes 2, 4, and 6). FADD and FLICE were able
to coimmunoprecipitate with Fas even in the presence of
E1B 19K (Fig. 8 a, lanes 3 and 5). This data suggests the
mechanism for protection by E1B 19K is not solely the se-
questration of FADD and FLICE to an insoluble intracel-
lular compartment, since both proteins were able to inter-
act with Fas at the plasma membrane.
E1B 19K Inhibits FLICE Activation
To address whether overexpression of FADD and FLICE
autocatalyzes FLICE activation in the presence of E1B
19K, HeLa cells were transiently transfected with FLICE
Figure 5. Bcl-2 does not substantially disrupt FADD filaments. HeLa cells were transfected with the expression plasmids indicated and
indirect immunofluorescence was performed 48 h posttransfection. HeLa cells were cotransfected with HA-tagged FLICE and Myc-
tagged Bcl-2 and then stained with an anti-HA polyclonal antibody (A) or an anti-Myc monoclonal antibody (B). In C, cells were trans-
fected with AU1-tagged FADD alone and visualized with an anti-FADD polyclonal antibody. In D and E, cells were transfected with
AU1-tagged FADD and Myc-tagged Bcl-2 and protein expression detected with an anti-FADD polyclonal antibody (D) and an anti-
Myc monoclonal antibody (E). In panels F–H, cells were transfected with AU1-tagged FADD, HA-tagged FLICE, and Myc-tagged Bcl-2.
Proteins were visualized with anti-FADD polyclonal antibody (F), anti-HA monoclonal antibody (G), and anti-Myc monoclonal anti-
body (H). All cells were also transfected with CrmA to retain cell viability.Perez and White E1B 19K Inhibits Adaptor-dependent Caspase Activation 1263
or FADD plus FLICE alone or in the presence of E1B
19K (Fig. 8 b). 7dl vector control was overexpressed as a
negative control for FLICE expression. Whole cell lysates
were produced 20 (data not shown) and 48 h posttransfec-
tion and then probed with an anti-HA polyclonal anti-
body. Full-length proFLICE appeared as a 66-kD band in
cells that overexpressed FLICE or FLICE plus E1B 19K
(Fig. 8 b, lanes 2 and 3). Due to z40% of the transfected
cells remaining viable, the inactive zymogen form of
FLICE was still detectable. Unprocessed full-length pro-
FLICE, however, disappeared when FADD and FLICE
were coexpressed, indicating that increased processing and
activation of FLICE had taken place (Fig. 8 b, lane 4). We
were not able to detect the 10-kD COOH-terminal cleav-
age product, which suggested that the activated forms of
cytosolic FLICE may have a short half-life. Coexpression
of E1B 19K, FADD, and FLICE inhibited FLICE activa-
tion as indicated by the abundance of unprocessed pro-
FLICE (Fig. 8 b, lane 5). These results suggest E1B 19K
blocks FLICE-mediated apoptosis, in a FADD-dependent
fashion, upstream of FLICE activation.
Discussion
We have established E1B 19K is highly efficient at inhibit-
ing FADD- but not FLICE-induced apoptosis. Coexpres-
sion of FADD and FLICE profoundly diminishes cell via-
bility and E1B 19K dramatically rescues cells from this
apoptosis. This mechanism for inhibition of cell death may
be functionally homologous to the C. elegans model for
abrogation of apoptosis. C. elegans encodes three integral
genes necessary for the regulation of programmed cell
death (Hengartner, 1996). The ced-3 gene encodes an ef-
fector protein that is homologous to the interleukin-1b–con-
verting enzyme ICE-like family members (Yuan et al.,
1993). Its activation is inhibited by the Ced-9 gene product
that is able to sequester Ced-3 through protein–protein
interactions (Chinnaiyan et al., 1997a,b; Seshagiri and
Miller, 1997; Spector et al., 1997; Wu et al., 1997). The Ced-
3–Ced-9 interaction is mediated by a third bridging protein
encoded by the ced-4 gene. This model for protection of cell
death can be applied to mammalian cells through protein
substitution. Several labs have shown Bcl-xL can inhibit
Figure 6. Bcl-xL attenuates the formation of FADD filaments. HeLa cells were transfected with the expression plasmids indicated and
indirect immunofluorescence was performed 48 h posttransfection. HeLa cells were cotransfected with HA-tagged FLICE and Flag-tagged
Bcl-xL and then stained with an anti-HA polyclonal antibody (A) or an anti-Flag monoclonal antibody (B). Cells were transfected with
AU1-tagged FADD alone and visualized with an anti-FADD polyclonal antibody (C). In D and E, cells were transfected with AU1-
tagged FADD and Flag-tagged Bcl-xL and protein expression was detected with an anti-FADD polyclonal antibody (D) and an anti-
Flag monoclonal antibody (E). In panels F–H, cells were transfected with AU1-tagged FADD, HA-tagged FLICE, and Flag-tagged Bcl-xL.
Proteins were visualized with anti-FADD polyclonal antibody (F), anti-HA monoclonal antibody (G), and anti-Flag monoclonal anti-
body (H). All cells were also transfected with CrmA to retain cell viability.The Journal of Cell Biology, Volume 141, 1998 1264
FLICE activation and, subsequently, cell death when in the
presence of the Ced-4 gene product (Chinnaiyan et al.,
1997b; Seshagiri and Miller, 1997; Wu et al., 1997).
The adenoviral E1B 19K protein is able to abrogate Fas-
mediated apoptosis likely through protein–protein inter-
actions with key DISC components. The FADD adaptor
molecule is required for E1B 19K to block FLICE-induced
cell death. However, another protein(s), posttranslational
modification and/or a conformational change of FADD
appears to be required for E1B 19K to interact with FADD
and for disruption of FADD filament formation.
Immunofluorescence studies reveal overexpression of
FADD causes FADD to form filaments within the cell (re-
fer to Fig. 3 C) (Siegel et al., 1998). Electron microscopy
indicates FADD forms higher order filamentous struc-
tures arranged in bundles (data not shown). These fila-
ments are localized in the cytosol as well as in the nucleus.
Furthermore, they do not associate with cytoskeletal struc-
tures such as vimentin (data not shown) or tubulin (Siegel
et al., 1998). Full-length FADD is known to self-associate
(Boldin et al., 1995), suggesting the filaments result from
FADD multimerization.
A FADD-DN expression vector containing a deletion
within the death effector domain does not self-associate
nor does it induce cell death (Boldin et al., 1995; Chin-
naiyan et al., 1996b). Overexpression of FADD-DN does
not cause filament formation but is rather localized dif-
fusely throughout the cell. This result implies that FADD
oligomerization may be required for mediating cell death.
This is similar to other death domain–containing mole-
cules such as Fas, whereby trimerization is necessary for
transduction of the death signal (Kischkel et al., 1995).
The DED, but not the DD, of FADD is able to directly
bind to full length FADD (Boldin et al., 1995). This sug-
gests the DED is essential for both multimerization and
for inducing cell death.
E1B 19K does not alter the subcellular localization of
FLICE but is able to strikingly disrupt FADD filament
formation and relocalize FADD into the membranous and
cytoskeletal elements of the cell where the E1B 19K pro-
tein is normally found. The disruption of FADD filaments
is concurrent with the ability of E1B 19K to block FADD-
induced apoptosis. E1B 19K also blocks FLICE-induced
cell death in the presence of FADD but apparently does
not block FLICE from associating with FADD in the cyto-
plasm or the DISC.
Indirect immunofluorescence (refer to Fig. 4) and sub-
cellular fractionation (data not shown) studies demon-
strate that E1B 19K is also able to sequester FLICE to an
insoluble intracellular compartment only in the presence
of FADD. These results further indicate FADD is acting
as an adaptor molecule bridging FLICE with E1B 19K.
Other viruses such as Molluscum contagiosum and equine
herpes-virus 2 are capable of blocking FADD-mediated
Figure 7. E1B 19K does not
associate with FADD or
FLICE in vitro. In vitro
translated [35S]methionine
FADD, FLICE, FADD-DN,
E1B 19K, and Nbk/Bik were
incubated as indicated and
immunoprecipitated with an
anti-FADD antibody (lanes
1 and 2) and an anti-E1B
19K antibody (lanes 3–6).
Arrows, in vitro translated
products.
Figure 8.( a ) FADD and FLICE coimmunoprecipitate with Fas
in the presence of E1B 19K. HeLa cells were transfected with 7dl
vector control (lanes 1 and 2), FADD, FLICE, and CrmA (lanes
3 and 4), or FADD, FLICE, E1B 19K, and CrmA (lanes 5 and 6)
and then immunoprecipitated with an anti–APO-1 antibody 48 h
posttransfection. In lanes 1, 3, and 5, cells were first stimulated
with anti–APO-1 antibody, lysed, and then immunoprecipitated
with the addition of protein A–Sepharose beads. In lanes 2, 4,
and 6, cells were lysed first and then immunoprecipitated with
anti–APO-1 antibody. Lanes 7–9 correspond to whole cell ex-
tracts used to verify equal protein expression. Samples were re-
solved on a 15% SDS-PAGE and subjected to Western analysis
with an anti-FADD polyclonal antibody (top panel) and an anti-
HA polyclonal antibody (bottom panel). (b) E1B 19K blocks up-
stream of FLICE activation. HeLa cells were transfected with 7dl
vector control, FLICE, or FLICE plus FADD alone or in the
presence of E1B 19K at concentrations indicated in the viability
assay (refer to Materials and Methods). Whole cell extracts were
made 48 h posttransfection, resolved by SDS-PAGE, and then
immunoblotted with an anti-HA polyclonal antibody.Perez and White E1B 19K Inhibits Adaptor-dependent Caspase Activation 1265
cell death, but not FLICE-induced apoptosis, through ex-
pression of viral inhibitory proteins MC159 and E8, re-
spectively (Hu et al., 1997; Thome et al., 1997). The mech-
anism used by these viral proteins is by direct interaction
with the inducers of cell death, FADD and FLICE, which
abrogates formation of a complete DISC and results in in-
hibition of apoptosis. Therefore, we propose E1B 19K
may act analogously and form a probably indirect physical
interaction with FADD, thereby causing an alteration in
its subcellular localization and ability to oligomerize. Since
we have been unable to detect binding of E1B 19K to
FADD, another protein, posttranslational modification,
and/or a conformational change of FADD may be re-
quired for E1B 19K to interact with the FADD–FLICE
complex and disrupt its function.
The current model of Fas activation proposes that het-
erooligomerization of FADD and FLICE at the DISC re-
sults in FLICE activation. Coimmunoprecipitation of
FADD and FLICE with Fas demonstrates FADD and
FLICE are recruited to the DISC upon Fas activation by
anti–APO-1 antibody (Kischkel et al., 1995; Muzio et al.,
1996). Thus, sequestration of FADD/FLICE into an insol-
uble intracellular compartment by E1B 19K may abrogate
activation of FLICE by preventing recruitment to the re-
ceptor complex upon Fas receptor stimulation. However,
FADD and FLICE recruitment occurs even in the pres-
ence of E1B 19K. Thus, we can conclude FADD and
FLICE are present at the DISC, but E1B 19K is still able
to abrogate cell death. Recent data has shown that FLICE
needs to be clustered for full activation and induction of
apoptosis (Muzio et al., 1998). Thus, we propose a mecha-
nism in which FADD needs to be multimerized at the
DISC, similar to Fas, to activate FLICE. E1B 19K may se-
quester a portion of the FADD molecules, thereby deplet-
ing the number of FADD molecules recruited to the DISC
and subsequently inhibiting its oligomerization and activa-
tion of FLICE.
Conflicting data has been reported by many labs as to
whether other Bcl-2 family members, particularly Bcl-2
and Bcl-xL, are able to block Fas-mediated apoptosis.
Even within the same cell line, Bcl-2 has been shown to be
either nonfunctional or act as a potent inhibitor of Fas-
mediated death (Armstrong et al., 1996; Chinnaiyan et al.,
1996a). These discrepancies may be due to differences in
cell type specificity, strength of the death signal, and levels
of expression of the inhibitory proteins. Our results dem-
onstrate Bcl-xL and E1B 19K efficiently block Fas-induced
cell death, whereas Bcl-2 functions poorly in the same as-
say. Bcl-xL inhibits FADD- but not FLICE-induced death
and is also able to block FLICE-mediated death in the
presence of FADD. These results are coincident with Bcl-
xL disrupting the formation of FADD filaments. Bcl-2,
however, appears to be only marginally effective in inhib-
iting Fas-mediated cell death and does not substantially al-
ter FADD filament formation. Recent evidence has shown
Bcl-2 is cleaved subsequent to anti-Fas antibody treat-
ment, generating a cleavage product that has proapoptotic
activity similar to that of Bax and Bak (Cheng et al., 1997).
E1B 19K, however, is not cleaved during the apoptotic
process to generate a proapoptotic derivative (Han et al.,
1996). The difference between the potent inhibitory activ-
ity of E1B 19K, in contrast to the weak effect of Bcl-2, in
Fas-mediated apoptosis may reside within this intrinsic
difference between E1B 19K and Bcl-2.
Coexpression of FADD and FLICE without E1B 19K
caused increased FLICE activation as indicated by the dis-
appearance of full-length FLICE. In contrast, the presence
of FLICE in the unprocessed pro form when coexpressed
with FADD and E1B 19K, indicates that E1B 19K expres-
sion inhibits FLICE activation. This result, however, does
not rule out the possibility that undetectable levels of pro-
cessed FLICE are present.
Bcl-xL appears to affect FADD and FLICE differently
than E1B 19K. Rather than diverting FADD and FLICE
into large aggregates, Bcl-xL appears to prevent FADD fil-
ament formation and FLICE recruitment into the fila-
ments. This may be a mechanism for inhibiting FADD
from promoting FLICE activation. However, Bcl-xL has
been reported to act downstream of FLICE activation
(Boise and Thompson, 1997). Whether dispersed FLICE,
in FADD- and Bcl-xL-expressing cells, is activated, has yet
to be determined. Nonetheless, E1B 19K appears to func-
tion differently than Bcl-xL to inhibit the Fas and TNFR-1
death-signaling pathway by blocking FLICE activation
subsequent to FADD recruitment.
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